Search
for
Sort by
Research 721–750 of 1000+
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Estrogens and the skin
- Feather arrays are patterned by interacting signalling and cell density waves
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Oxidative stress in ageing of hair
- Extraskeletal actions of vitamin D
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Wnt and Notch signaling pathway involved in wound healing by targeting c-Myc and Hes1 separately
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Regulatory T cells in skin
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Aging of hair
- Control of hair follicle cell fate by underlying mesenchyme through a CSL–Wnt5a–FoxN1 regulatory axis
- Obesity and polycystic ovary syndrome
- Learning from nudity: lessons from the nude phenotype
- Alopecia Areata Update
- Circadian clocks: from stem cells to tissue homeostasis and regeneration
- Olfactory receptor OR2AT4 regulates human hair growth
- TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
- Hardwiring Stem Cell Communication through Tissue Structure
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Methotrexate in dermatology
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Beyond Expectations
- Red ginseng monograph
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing